Artivion, Inc. (AORT) vs Tandem Diabetes Care, Inc. (TNDM)
Artivion, Inc. and Tandem Diabetes Care, Inc. are both Medical Devices companies. Artivion, Inc. and Tandem Diabetes Care, Inc. are of similar size ($1.1B and $1.1B). Artivion, Inc. grew revenue faster over the last twelve months: 16.4% against 3.96%. Artivion, Inc. has the higher net margin (−0.67% vs −6.08%) and the higher return on invested capital (1.76% vs −10.3%). Across the 18 metrics below, Artivion, Inc. leads on 14 and Tandem Diabetes Care, Inc. on 4.
Valuation
Profitability
| Metric | AORT | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 64.37% | 56.01% | 56.01% |
| Operating margin | 4.38% | (4.40%) | (15.03%) |
| Net margin | (0.67%) | (6.08%) | (20.40%) |
| Free cash flow margin | (1.94%) | (2.56%) | (7.24%) |
| Return on equity | (0.73%) | (48.03%) | (15.32%) |
| Return on assets | (0.33%) | (6.24%) | (19.72%) |
| Return on invested capital | 1.76% | (10.33%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack